Nov 23 2013
The spin-off from Joseph Fourier University, Grenoble (UJF), starts its incubation period accompanied by Grenoble’s innovation accelerators, Gravit and GATE1. Based on research by its leader, Prof. Jean Viallet (Associate Professor at UJF), the team intends to develop very promising in vivo assays for drug development, particularly for cancer treatments
Nov 13
2024
Come see us at the EPAA
Come see us at the EPAA (European Partnership for Alternative Approaches to Animal Testing) 2024 Annual Conference INOVOTION will be at the European Partnership for Alternative Approaches to Animal Testing (EPAA) Annual Conference 2024, November […]
Nov 6-10
2024
Come see us at the SITC
Come see us at the SITC (Society for Immunotherapy of Cancer) 39th Annual Meeting, November 6-10, 2024, in Houston! SITC 2024 is the world’s leading showcase of advances in cancer immunology and immunotherapy, bringing together […]
Nov 4-6
2024
Come see us at Bio-Europe Fall
